“Innovation Criteria” Could Help Focus Health Spending, J&J Exec Suggests
Executive Summary
Policymakers should attempt to define "innovation criteria" to help guide health care resources toward more significant technological advances, Johnson & Johnson Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia
You may also be interested in...
J&J Focusing On “Product Solutions”; Diabetes Care May Be Early Model
Johnson & Johnson is moving towards a business model focused on offering "product solutions" for the health care system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia
“Functional Equivalence” Upheld In Court; Amgen Cannot Challenge Decision
The Centers for Medicare & Medicaid Services has the authority to enforce its position that Amgen's Aranesp is "functionally equivalent" to J&J's Procrit for reimbursement purposes, a D.C. federal appeals court ruled
Outcomes Research Should Come After Approval, FDA’s McClellan Says
The appropriate timing for outcomes research is after a product is approved for commercial marketing, FDA Commissioner McClellan told a recent conference on outcomes research sponsored by Merck and AARP